Armenta was established to address the most pressing disease affecting dairy farming today: Bovine Mastitis. Losses due to bovine mastitis can reach several billion dollars per year. Armenta developed innovative non-invasive; antibiotics free therapies based on acoustic pulse technology (APT). APT has been used for over 20 years in human healthcare treating inflammatory diseases. Armenta employs experts in acoustic pulse treatment and engine...read more
Gil Hakim
Chairman and CEO
Eddie Papirov
Founder & CTO
Prof. Gabriel Leitner
CSO